Sound Income Strategies’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
Other funds holding TVRD
AFG
DWAM
SC
GCP
AAP
PAP
Sound Income Strategies's TVRD Position: Q2 2026 in Review
Sound Income Strategies sold out of Tvardi Therapeutics (TVRD) in Q2 2026, closing a stake of 2 shares — an estimated $6 sold.
Sound Income Strategies first reported a position in TVRD in Q1 2020 and held it in 23 quarters. The position peaked at $2.17K in Q1 2021. 34 funds tracked by Wall St. Rank hold TVRD as of Q2 2026.
- Sound Income Strategies reported no remaining Tvardi Therapeutics position as of Q2 2026 after selling out during the quarter.
- Sound Income Strategies sold 2 Tvardi Therapeutics shares in Q2 2026, an estimated $6.
- Sound Income Strategies first reported a position in Tvardi Therapeutics in Q1 2020 and held it in 23 quarters.
- Sound Income Strategies's Tvardi Therapeutics position peaked at $2.17K in Q1 2021.
- 34 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2026.
Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.